Wu DM et al.S100A9 gene silencing inhibits the release of pro-inflammatory cytokines by blocking the IL-17 signalling pathway in mice with acute pancreatitis.J Cell Mol Med 22:2378-2389 (2018).
Pfaff CM et al.The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.Sci Rep 7:15631 (2017).
Carpino G et al.PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress.Sci Rep 7:15756 (2017).
Langley SR et al.Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques.J Clin Invest 127:1546-1560 (2017).
Nakhlé J et al.Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer.Oncoimmunology 5:e1145333 (2016).
Carpino G et al.Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.PLoS One 11:e0157246 (2016).
Saygideger-Kont Y et al.Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells.Neoplasia 18:111-20 (2016).
Saul MJ et al.UPF1 regulates myeloid cell functions and S100A9 expression by the hnRNP E2/miRNA-328 balance.Sci Rep 6:31995 (2016).
Yu J et al.High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.Oncotarget 7:75279-75292 (2016).
Zhang L et al.Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis.Mol Med Rep 11:4093-100 (2015).
Caseiro A et al.Pursuing type 1 diabetes mellitus and related complications through urinary proteomics.Transl Res N/A:N/A (2013).
O'Dwyer D et al.The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.PLoS One 6:e27718 (2011).